| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 12/02/2009 | CN101590062A Use of pregnane-diones or diols as neuropathic analgesic agents |
| 11/26/2009 | US20090291933 Solid state forms of a pharmaceutical |
| 11/25/2009 | CN101585862A Novel steroids |
| 10/22/2009 | US20090264396 17Alpha, 21-Dihydroxypregnene esters as antiandrogenic agents |
| 10/21/2009 | CN101559287A Method for drying hydrocortisone sodium succinate asepsis powder |
| 10/20/2009 | US7605151 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 10/15/2009 | WO2009019138A3 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 10/14/2009 | EP2108653A1 Process for preparing budesonide |
| 10/08/2009 | WO2009124300A2 Solid state forms of a pharmaceutical |
| 10/08/2009 | CA2728889A1 Solid state forms of a pharmaceutical |
| 10/06/2009 | US7598234 Steroid derived antibiotics |
| 09/23/2009 | CN101537344A Monolithic column, preparation method and application thereof |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/02/2009 | CN101518537A Preventives/remedies for inflammatory airway diseases |
| 09/01/2009 | CA2438799C Preventative of therapeutic agent for inflammatory respiratory tract disease |
| 08/24/2009 | CA2598095A1 Method of relieving or avoiding side effect of steroid |
| 08/06/2009 | WO2009044251A3 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 07/08/2009 | CN100509839C Method for producing 5 alpha-pregnane derivative |
| 07/08/2009 | CN100509838C Method for producing 5 alpha-pregnane derivative |
| 06/25/2009 | US20090163456 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 06/24/2009 | CN100503629C Method for producing 5alpha-pregnane derivative |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 05/27/2009 | EP1395544A4 Methods of making 21- 4'-(nitrooxyalkyl) benzoate corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 05/26/2009 | CA2454675C 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/22/2009 | WO2009032321A3 A method for treating diabetes |
| 05/14/2009 | US20090124591 Synthesis and Use of Cationic Steroids for Anti-Inflammatory Drug Therapy |
| 05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 04/29/2009 | EP1416937B1 Prophylactic and therapeutic use of hydroxysteroids |
| 04/29/2009 | CN101418029A Method for synthesizing methylprednisolone |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 04/28/2009 | CA2344686C High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/22/2009 | CN101412742A Nitric acid ester medicament for inhibiting angiogenesis |
| 04/22/2009 | CN101412741A Composition with methylprednisolone palmitate as active component for treating local inflammation |
| 04/09/2009 | US20090093638 Allylic Oxidations Catalyzed by Dirhodium Catalysts under Aqueous Conditions |
| 04/09/2009 | CA2701713A1 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/01/2009 | CN101397324A Preparation of metacortandralone and derivatives thereof |
| 04/01/2009 | CN101397323A Preparation of hydrocortisone |
| 04/01/2009 | CN101397322A Preparation of desoximetasone |
| 04/01/2009 | CN101397321A Preparation of hydrocortisone and derivatives thereof |
| 04/01/2009 | CN101397320A Method for preparing dexamethasone and series products thereof |
| 04/01/2009 | CN101397319A Method for preparing betamethasone and series products thereof |
| 04/01/2009 | CN101397318A Technique for refining fluocinonide 9 fluorine |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 03/26/2009 | US20090081297 Use of surface tension reducing agents in aerosol formulations |
| 03/26/2009 | US20090081161 Treatment of neoplasms with viruses |
| 03/18/2009 | CN100469764C Vitamin D derivatives |
| 03/12/2009 | WO2009032321A2 A method for treating diabetes |
| 03/12/2009 | CA2697744A1 A method for treating diabetes |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/05/2009 | US20090061358 Novel photoacid generator, resist composition, and patterning process |
| 02/19/2009 | WO2009022477A1 Norbornene polymers bearing biologically active substances bonded thereto, proces for production of the same and use thereof |
| 02/12/2009 | CA2691445A1 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 02/10/2009 | CA2429574C Sterilisation of pharmaceuticals |
| 01/28/2009 | CN101353368A Pregna medicament for treating tumor |
| 12/23/2008 | US7468362 Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists |
| 12/03/2008 | CN100439388C Synthesis process of methyl prednisolone aceponate |
| 11/26/2008 | CN100436473C Momertasone furoate intermediate 21-ester and its prepn |
| 11/19/2008 | CN100434436C NO donor-type hydrocortisone derivative, its preparing method and antiphlogistic use |
| 11/12/2008 | CN100432093C High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/06/2008 | WO2008067086A3 Compositions and methods for suppressing endometrial proliferation |
| 09/25/2008 | US20080234506 Fluorination; catalytic acetylation |
| 09/24/2008 | CN100420699C Process for the production of tibolone |
| 09/18/2008 | US20080227764 E.g., 3,-30-pregnanediones or 11,20-pregnanedioles; optionally in association with one or more other analgesic compounds such as opioids; does not result in overt sedation |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/11/2008 | US20080221072 Fatty Acid Modified Forms of Glucocorticoids |
| 08/14/2008 | WO2008097442A1 Glucocorticoid-lowering composition |
| 08/13/2008 | CN101243103A Therapeutic agent for hypertension |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/02/2008 | CN101209261A Natural sex hormone extracted by supercritical CO2 extraction method from pilose antler |
| 06/25/2008 | CN100396693C Preparation method of 1,4-dipregnene-16-beta-methyl-17-alpha-21-bihydroxy object |
| 06/24/2008 | US7390796 Fatty acid modified forms of glucocorticoids |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/18/2008 | EP1301526B1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 06/18/2008 | CN101200485A Production technique of drug intermediates |
| 06/18/2008 | CN101200484A Production technique of steroid ring-opening product |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139519 Applying moist heat to a suspension of a labile glucocorticosteroid, in particular, budesonide or beclomethasone dipropionate, for a sterilizing-effective time; for preventing, reversing, and/or reducing symptoms of allergic and/or inflammatory conditions |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | CA2673128A1 Compositions and methods for suppressing endometrial proliferation |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 05/29/2008 | CA2833976A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/28/2008 | EP1344526B1 Preventives/remedies for inflammatory airway diseases |
| 05/21/2008 | EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/20/2008 | US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes |
| 05/14/2008 | CN100387611C 16 alpha-bromosteroid compound and its synthesis method |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/08/2008 | US20080107736 Nanoparticulate suspension of a corticosteroid compound; a second solvent promotes active compound precipitation; substantially free of surfactant; optically clear; particulate of a desired particle size; prepared without the use of mechanical shearing; increased bioavailability |
| 05/01/2008 | US20080103119 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 04/30/2008 | CN101168555A Preparation of medicine and derivative thereof |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/16/2008 | CN101161681A Method for preparing double-flumethasone artificial antigen |
| 04/16/2008 | CN101161680A Method for preparing beta-corlan artificial antigen |
| 04/16/2008 | CN101161679A Method for preparing dexamethasone artificial antigen |